Azona

Quick links to important sections

Azona

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azona

What is Azona?

Azona is a pharmacological treatment primarily utilized in the management of certain psychiatric and neurological conditions. It belongs to a class of medications designed to modulate neurotransmitter activity within the central nervous system. By interacting with specific receptors in the brain, it helps to stabilize chemical signaling that may be imbalanced due to various underlying health factors.

Mechanism of Action

The active components in Azona work by influencing the uptake and binding of chemicals such as serotonin or dopamine, depending on the specific clinical formulation. This modulation is intended to assist in the regulation of mood, cognitive function, or motor control. Because it targets the internal chemistry of the brain, the effects of the medication are typically observed over a period of consistent use rather than immediately after the first application.

Clinical Applications

Azona is most commonly associated with the treatment of depressive disorders, anxiety-related conditions, or specific types of chronic pain management where neurological pathways are involved. It is designed to be part of a broader therapeutic strategy to help individuals manage persistent symptoms that interfere with daily functioning.

Form and Composition

Azona is typically produced in oral formats, such as tablets or capsules, to allow for controlled systemic absorption. The formulation is engineered to maintain steady levels of the compound in the bloodstream, which is essential for achieving the intended neurological stabilization. The specific chemical structure of Azona distinguishes it from other medications in the same class, allowing for a unique profile of interaction with the body’s internal systems.

Regulatory References

  1. Trazodone Clinical Review

What side effects are possible with Azona?

Possible Side Effects and Safety Information

The safety profile for Azona (Trazodone hydrochloride) is formally structured by government regulatory agencies, classifying potential adverse reactions based on their frequency and the physiological systems affected. These classifications are defined in official prescribing information.


Adverse Reaction Classification

Side effects are categorized based on their official reported occurrence rate:

  • Very Common: Includes effects like somnolence (drowsiness), dizziness, dry mouth, and nausea. These are most frequently observed reactions, often reported at the start of treatment or following dose increases, according to regulatory documentation.
  • Common: Includes headache, confusion, tremor, blurred vision, orthostatic hypotension (a drop in blood pressure upon standing), and general fatigue. These effects are formally documented as occurring in a significant percentage of patients.

System-Organ Classes and Serious Reactions

Adverse reactions are grouped by the body systems they affect, including the Nervous System and the Gastrointestinal System. Official labeling also documents rare but clinically important reactions:

  • Serious Adverse Reactions: The regulatory profile explicitly lists the risk of priapism (a prolonged, painful erection), blood dyscrasias (severe blood disorders like agranulocytosis), and serious cardiac arrhythmias.
  • Population Notes and Restrictions: Cautions are noted for specific groups, such as older adults, who may be more susceptible to sedation and orthostatic hypotension. Furthermore, the safety and efficacy of Azona have not been established in the pediatric population. The medicine is formally restricted from use (contraindicated) in individuals recovering immediately from a myocardial infarction.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the Azona (Trazodone hydrochloride) overdose profile based on risks of severe CNS and cardiovascular instability, which necessitates immediate medical intervention.

Category Documented Manifestations
Common Signs Drowsiness, Vomiting, Lack of coordination
Severe Outcomes Respiratory arrest, Seizures, Coma, Irregular heartbeat, Hypotension, Serotonin Syndrome

Serious or potentially fatal outcomes, including death, have occurred in cases involving Trazodone co-ingested with other substances, particularly alcohol or other CNS depressants.

The label specifies that no specific antidote is known for Trazodone overdose. Management must be symptomatic and supportive, often requiring close cardiac monitoring due to the potential for EKG changes.

When Urgent Medical Help Is Required

Regulators mandate that individuals seek immediate medical attention for any suspected overdose. Additionally, men who experience priapism (a prolonged erection) must immediately discontinue the drug and seek emergency medical attention to prevent permanent tissue damage. For guidance on current management, individuals are directed to contact a poison control center immediately.

Therapeutic Uses of Azona

Therapeutic Indications

Azona (trazodone hydrochloride) is a medication primarily classified as a serotonin antagonist and reuptake inhibitor (SARI). Its primary therapeutic application is the treatment of depressive disorders. It is utilized to alleviate symptoms associated with clinical depression, including persistent sadness, loss of interest in daily activities, and changes in appetite or energy levels.

Treatment of Major Depressive Disorder

In the management of major depressive disorder, Azona works by modulating the levels of neurotransmitters in the brain. By affecting serotonin levels, it helps to stabilize mood and improve the emotional state of patients. It is effective in treating both the emotional and physical manifestations of depression.

Management of Related Symptoms

While its primary indication is depression, Azona is frequently observed to provide benefits for specific symptoms that often accompany depressive episodes:

  • Sleep Disturbances: Due to its sedative properties, Azona is often beneficial for patients experiencing insomnia or fragmented sleep associated with their depressive disorder.
  • Anxiety Symptoms: It may help in reducing the symptoms of anxiety that frequently co-occur with depression, contributing to a more comprehensive stabilization of the patient's condition.

Mechanism and Benefits

The therapeutic benefit of Azona is derived from its dual mechanism of action. It blocks the reuptake of serotonin while simultaneously blocking specific serotonin receptors. This balanced approach helps in restoring chemical equilibrium in the central nervous system.

Patients using Azona for the indicated purposes may experience:

  • Improved mood and emotional regulation.
  • Reduced feelings of restlessness or agitation.
  • Better sleep patterns and quality.
  • Enhanced ability to perform daily tasks as depressive symptoms recede.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Official Eligibility Profile

Azona (Trazodone hydrochloride) is established and approved for use in adults aged 18 and over. The official population eligibility profile defines clear restrictions and absolute prohibitions based on government regulatory documentation.


Eligibility Classification Populations/Conditions
Absolute Contraindications (Must NOT Use) Hypersensitivity to Azona; use with, or within 14 days of discontinuing, a Monoamine Oxidase Inhibitor (MAOI); the acute recovery phase following a myocardial infarction.
Use Not Established (Not Recommended) Children and adolescents under 18 years; safety and efficacy are not established in this age group, per regulatory guidance.
Conditional Use (Use with Caution) Patients with pre-existing cardiac disease (e.g., arrhythmia); patients with severe hepatic or renal impairment; very elderly or frail patients; and patients with a history of Bipolar Disorder or Epilepsy.

For pregnant women, use is generally restricted to situations where the potential benefit to the patient is judged to outweigh the potential risk. The drug is excreted into human milk, necessitating a cautious decision regarding use while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Azona (Trazodone hydrochloride) as defined by government regulatory authorities.

Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs), including agents with MAOI activity like Linezolid and Intravenous Methylene Blue, is strictly prohibited. A mandatory 14-day washout period is required between stopping an MAOI and starting Azona, and vice-versa.

Pharmacokinetic Interactions (Metabolic)

Azona's clearance is subject to Cytochrome P450 3A4 (CYP3A4)-mediated metabolism. Strong CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir) can significantly increase the plasma concentration of Trazodone. Conversely, strong CYP3A4 inducers (e.g., Carbamazepine, St. John's Wort) may reduce Trazodone exposure.

Pharmacodynamic Interactions and Substance Restrictions

Official labeling documents two major additive risks:

  • Serotonergic Agents: Co-administration with other serotonergic agents (e.g., SSRIs, Triptans) is documented to increase the risk of Serotonin Syndrome.
  • CNS Depressants: Azona enhances the effects of alcohol and other Central Nervous System depressants, leading to increased sedation.
  • Anticoagulants: Concomitant use with anticoagulants (e.g., Warfarin) or antiplatelet agents increases the risk of abnormal bleeding.

Population-specific caution is also documented; for instance, the elderly may be at greater risk of hyponatremia.

Mechanism of Action

The mechanism of Azona (Trazodone hydrochloride) is defined by its ability to engage multiple distinct biological targets simultaneously, primarily through receptor antagonism rather than high-affinity reuptake inhibition.


Primary Mechanism: Serotonergic Pathway Modulation via Receptor Antagonism

This domain covers the drug's action: the high-affinity antagonism of the Serotonin 5- HT2A receptor in the central nervous system. Blocking this receptor changes how serotonin affects specific neural circuits, which over time allows for the functional adjustment of activity within other key monoaminergic pathways, leading to altered signaling dynamics in those systems.


CNS Arousal System Modulation via H1 and alpha1 Receptor Blockade

This domain is driven by the molecule's antagonism of central Histamine H1 and alpha1-Adrenergic receptors. This dual blockade directly interferes with the core signaling pathways responsible for promoting wakefulness and alertness, resulting in the substantial suppression of central nervous system arousal signals and a resulting physiological decrease in activity.

Dosage and Administration Information

Administration Overview

Azona is typically administered according to a routine established by a healthcare professional. Consistency in application or intake is often recommended to maintain steady levels of the medication within the body. Depending on the specific formulation, it may be used with or without food, though individual tolerance and specific medical guidance usually determine the most appropriate method.

Preparation and Handling

Before using the medication, it is common practice to ensure that the hands are clean and the area of application, if applicable, is prepared. If the medication is in a liquid form, it may require gentle agitation or specific measuring tools to ensure the correct volume is utilized. For oral solid forms, the medication is generally swallowed whole unless otherwise specified by a healthcare provider.

Routine Integration

Integrating the medication into a daily schedule can help in maintaining the prescribed frequency. If a session is missed, individuals typically continue with the next scheduled application rather than attempting to compensate. The duration of use is determined by the underlying condition being addressed and the observed response to the medication over time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Azona

This section summarizes the research that has been conducted on Azona (Trazodone), describing the types of studies, the populations they focused on, and the kinds of outcomes that were measured. Research provides context but not individual predictions.


Evidence for Use in Major Depressive Disorder (MDD)

Research examined Azona in adults presenting with Major Depressive Disorder (MDD), which is a condition involving periods of heightened symptoms and functional limitations.

These studies include short-term (6 to 12 weeks), randomized controlled trials (RCTs) where Azona was evaluated in comparison to an inactive substance or to other commonly used antidepressant medications. The outcomes measured typically include how symptoms evolved in the observed populations, such as changes in standardized scores for depressive mood, and the proportional of participants meeting predefined symptom change criteria during the study period. Studies also explored patient-reported outcomes describing perceived discomfort and overall outcomes reflecting daily functioning or activity level.


Evidence for Use in Sleep Disturbances

Research explored whether short-term symptom changes related to sleep disturbances was observed in cohorts where these occur alongside mood or anxiety conditions.

Studies often monitored objective sleep parameters using tools like polysomnography (PSG), which measures physiological strain or stress during sleep. Research examined specific factors such as total sleep time (TST), the time it takes to fall asleep, and the frequency of nocturnal awakenings. Systematic reviews reported patterns observed in the studies related to objective sleep parameters, such as TST, N3 stage, and time to sleep onset.


Long-Term Study and Follow-up Duration

Most definitive efficacy studies are designed to assess the acute phase of treatment, meaning the follow-up durations were limited, typically lasting only 6 to 12 weeks.

Some open-label, observational studies were observed in settings to explore responses over more extended time intervals, tracking patient experience for up to 24 weeks. However, because these extended evaluations were often observational rather than controlled, there is limited information for long-term outcomes from the highest-quality, randomized study designs. Long-term effects are not fully established in the same manner as short-term symptom change.

Key Studies & References

  1. Trazodone Clinical Review (NIH Bookshelf)
  2. NIH MedlinePlus Drug Information overview (Trazodone)
  3. The efficacy and safety of trazodone for sleep problems in depressive patients: a GRADE-assessed systematic review and meta-analysis of clinical trials
  4. Trazodone: a multifunctional antidepressant. Evaluation of its properties and real-world use
  5. Trazodone effectiveness in depression: impacts of trazodone extended release vs SSRIs on the health status and quality of life of patients with major depressive disorder
  6. Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study
  7. TED—Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode—Preliminary Report

Frequently Asked Questions (FAQ)

Common questions about Azona (FAQ)


Q: How quickly should I expect Azona to start working?

A: Azona's active component is absorbed relatively quickly, with the concentration peaking in the blood about one hour after taking the immediate-release form. However, regulatory documents and research indicate that changes in reported symptoms, such as those related to mood and sleep, have typically been observed over several weeks in studies.


Q: What happens if I forget to take a dose of Azona?

A: Official patient information suggests that if a dose of Azona is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the regulatory guidance is to simply skip the missed dose and continue the regular schedule. Official guidance indicates that two doses should not be taken together to compensate for a missed dose.


Q: What if I drink alcohol while taking Azona?

A: Official labeling advises that Azona can enhance the effects of alcohol, potentially leading to increased sedation, drowsiness, and impaired motor or cognitive function. Regulatory guidelines advise that discussing the use of alcoholic beverages with a healthcare provider is appropriate, as Azona may enhance alcohol's effects.


Q: Can women who are planning pregnancy use Azona?

A: Studies examining Azona use in early pregnancy have not identified a significant increase in the risk of major birth defects. Women who are planning pregnancy are advised in official guidance to discuss treatment options with a healthcare provider. This allows for an assessment of the risks of using the medication versus the risks associated with an untreated medical condition.


Q: Does Azona interact with common over-the-counter pain relievers?

A: Yes, regulatory documents note that co-administration with nonsteroidal anti-inflammatory drugs (NSAIDs, like ibuprofen) or aspirin may increase a person’s risk of abnormal bleeding. The regulatory documents state that this combination should be considered by a prescribing professional.


Q: What is Azona's official safety classification (e.g., in pregnancy)?

A: Under the updated FDA system, Azona is not assigned a simple letter category for use during pregnancy. Instead, the official product label provides a detailed Pregnancy Risk Summary. This summary contains all available data from human and animal studies, and the available data must be assessed by the prescribing professional.


Q: What is the difference between Azona and its active metabolite?

A: When Azona's active component (Trazodone) is processed by the body, it creates another active substance called m-chlorophenylpiperazine (mCPP). While Azona primarily works by blocking certain serotonin receptors, its metabolite, mCPP, is defined by research as acting as an agonist (a stimulating agent) at some of those same receptors.


Q: Does Azona have a black box warning?

A: Yes, Azona is subject to a regulatory Boxed Warning (often called a 'Black Box Warning') from the FDA. This warning alerts users that, similar to other antidepressant medications, it may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults, particularly those up to age 24.


Q: Is Azona the same kind of drug as [Competitor A]?

A: Azona is formally classified as an Atypical Antidepressant and belongs to the Serotonin Antagonist and Reuptake Inhibitor (SARI) group. Official classification is used to distinguish it from other common antidepressant classes, such as SSRIs, because Azona's main pharmacological potency is on receptor blockade rather than strong reuptake inhibition.


Q: Are there generic versions of Azona available?

A: Yes, the active ingredient in Azona, Trazodone hydrochloride, is widely available in generic formulations. Regulatory information confirms that in jurisdictions like the United States, all original brand-name products containing this ingredient have been discontinued.


Q: How long does Azona stay in your system after stopping?

A: Regulatory data indicates that the time it takes for half of the drug to be eliminated from the body (the half-life) is approximately 5 to 13 hours. It is generally understood that a medication is substantially cleared from the body within one to three days after the last dose.


Q: Is Azona considered a controlled substance?

A: No, regulatory information from the FDA explicitly states that Azona (Trazodone hydrochloride) is not a controlled substance under the U.S. Controlled Substances Act. This classification relates to its assessed potential for dependence or abuse.


Q: What is the typical age range of people who use Azona?

A: Azona is approved for use in adults, meaning individuals aged 18 and older. Official notes indicate that it is also commonly used in the geriatric population for certain symptoms. The safety and effectiveness of the medication have not been established in anyone under the age of 18.


Q: Is it true that Azona can make you feel dizzy?

A: Yes, official safety documentation lists dizziness and somnolence (drowsiness) as very common adverse reactions. This means these effects are frequently observed, particularly when treatment is first initiated or if the dosage is increased.


Q: Is there a high chance of addiction or dependence with Azona?

A: Regulatory documents indicate that Azona is not a controlled substance and has a low potential for addiction liability. However, regulatory advice specifies the need for a gradual reduction (tapering) when stopping, which indicates the potential for physical dependence and withdrawal symptoms if use is discontinued suddenly.


Q: Why do some people stop taking Azona?

A: Common reasons for discontinuation mentioned in clinical research and patient summaries include side effects, such as excessive sedation, dizziness, or orthostatic hypotension (a drop in blood pressure when standing). Discontinuation can also relate to the experience of withdrawal symptoms if the gradual reduction process is not followed.


Q: Can men using Azona experience specific side effects?

A: Yes, official safety documentation warns of the specific risk of priapism (a prolonged, painful erection) in men, which requires immediate medical attention. Additionally, sexual side effects, such as decreased sex drive and erection difficulties, are listed in the official profile.


Q: Is Azona approved in other countries besides the US?

A: Yes, Azona is a prescription medicine approved and used for treatment in numerous jurisdictions globally, including the European Union (EMA), the United Kingdom (MHRA), Canada, and Australia (TGA).


Q: Can taking Azona affect my vision?

A: Yes, official adverse reaction lists include blurred vision as a common side effect. Regulatory warnings also advise caution regarding the potential risk of angle-closure glaucoma and recommend avoiding its use in patients with untreated narrow angles.


Q: What if I accidentally take two doses of Azona close together?

A: Taking more than the prescribed amount may lead to increased symptoms of overdose. These effects can include confusion, extreme sleepiness, vomiting, dizziness, and, in severe cases, seizures or heart and breathing problems. If this occurs, seeking immediate medical advice is appropriate.


Q: What is the chemical class or category of Azona?

A: Azona is classified pharmacologically as an Atypical Antidepressant and belongs to the Serotonin Antagonist and Reuptake Inhibitor (SARI) group of medicines. It is also structurally described as a Phenylpiperazine derivative.

How should Azona be stored and disposed of?

Azona should be stored correctly to maintain its effectiveness and safety.

Storage Guidelines

Storage Location General Instructions
Temperature Keep at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). Avoid excessive heat or freezing.
Environment Store in a cool, dry place, away from moisture and direct light. Do not store in the bathroom or near the kitchen stove.
Safety Always keep Azona out of sight and reach of children and pets.

Disposal of Unused Medication

The most recommended method for disposing of unused, unwanted, or expired Azona is to use a community drug take-back program or a disposal kiosk available at authorized pharmacies or law enforcement locations. If a take-back option is not available, most medicines can be thrown into household trash by following these steps:

  1. Remove Azona from its original container.
  2. Mix it with an undesirable substance, such as used coffee grounds, dirt, or cat litter. Do not crush tablets or capsules.
  3. Place the mixture in a sealable bag or container to prevent leakage.
  4. Throw the sealed container into the household trash.

Before disposal, scratch out all personal information on the prescription label to protect privacy. Do not flush Azona down the toilet or pour it down the sink unless the drug's specific instructions explicitly advise doing so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azona found in:

A-Z Index: